CTSO: CytoSorbents Potential for High Margin Revenue Growth Supports Price Target of $4.00 [Yahoo! Finance]
Cytosorbents Corporation (CTSO)
Last cytosorbents corporation earnings: 11/5 04:15 pm
Check Earnings Report
US:NASDAQ Investor Relations:
cytosorbents.com
Company Research
Source: Yahoo! Finance
CytoSorbents (NASDAQ:CTSO) reported 2nd quarter 2024 results on August 13th and the results were mostly above our expectations. For the 2nd quarter of 2024, total revenues increased approximately 5.0% to $9.9 million. Total product sales were $8.8 million, an increase of 9.5% from the 2nd quarter of 2023. Grant income was $1.05 million in the 2nd quarter of 2024 compared to $1.35 million in the prior year period. Product gross margin in the 2nd quarter increased to approximately 75% compared to 74% in the prior year period primarily due to greater efficiencies being realized at the new manufacturing facility in Princeton, New Jersey. As product revenues continue to grow, gross margins are expected to reach 80% over time. During the 2nd quarter, research and development expenses were approximately $1.5 million compared to approximately $3.7 million for the 2nd quarter of 2023. This decrease was primarily due to a decrease in clinical trial costs related to the completion of the ST
Show less
Read more
Impact Snapshot
Event Time:
CTSO
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CTSO alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CTSO alerts
High impacting Cytosorbents Corporation news events
Weekly update
A roundup of the hottest topics
CTSO
News
- Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- Cytosorbents Co. (NASDAQ: CTSO) is now covered by analysts at StockNews.com. They set a "hold" rating on the stock.MarketBeat
- CytoSorbents to Present at the H.C. Wainwright 26?? Annual Global Investment ConferenceGlobeNewswire
CTSO
Earnings
- 8/13/24 - Beat
CTSO
Analyst Actions
- 8/14/24 - HC Wainwright
CTSO
Sec Filings
- 9/26/24 - Form S-3/A
- 8/20/24 - Form 8-K
- 8/16/24 - Form 4
- CTSO's page on the SEC website